Lista de obras - Ghazaleh Tabatabai - Dominio Público Uruguay

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma

scientific article published on 27 November 2019

ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.

artículo científico publicado en 2017

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo

artículo científico publicado en 2010

ATRX immunostaining predicts IDH and H3F3A status in gliomas

artículo científico publicado en 2016

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

artículo científico publicado en 2013

Actively personalized vaccination trial for newly diagnosed glioblastoma

scientific article published on 19 December 2018

Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas

artículo científico publicado en 2017

Angiogenesis inhibition in neurooncology. A very promising therapy strategy for malignant glioma

artículo científico publicado en 2010

Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial

scientific article published on 19 July 2019

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.

artículo científico publicado en 2018

CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells

artículo científico publicado en 2011

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake

scientific article published on 11 July 2019

CS-35TGF-β INDUCES AND BMP SUPPRESSES VEGF RELEASE DEPENDING ON SMAD2/3 VERSUS SMAD1/5/8 SIGNALING IN GLIOBLASTOMA.

artículo científico publicado en 2014

Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas

scientific article published on 01 January 2019

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

artículo científico publicado en 2009

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

artículo científico publicado en 2014

Clinical implications of molecular neuropathology and biomarkers for malignant glioma

artículo científico publicado en 2012

Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival

artículo científico publicado en 2009

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial

artículo científico publicado en 2016

Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis

artículo científico publicado en 2020

De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival

artículo científico publicado en 2007

Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury

artículo científico publicado en 2012

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

artículo científico publicado en 2021

Diagnostic value of WT1 in neuroepithelial tumours

scientific article published on 07 May 2008

Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma

artículo científico publicado en 2014

Effect of Perfusion on Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of Integrated 2016 WHO Glioma Grades : A Cross-Sectional Observational Study

artículo científico publicado en 2017

Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma

article

Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.

artículo científico publicado en 2007

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

artículo científico publicado en 2008

Erratum to: In vivo molecular profiling of human glioma using diffusion kurtosis imaging

artículo científico publicado en 2016

Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.

artículo científico publicado en 2009

Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival

artículo científico publicado en 2007

GDF-15 contributes to proliferation and immune escape of malignant gliomas

artículo científico publicado en 2010

Glioblastoma stem cells ⬇️

artículo científico publicado el 21 de enero de 2011

Glioblastoma: State of the Art and Future Perspectives

artículo científico publicado en 2019

Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion

artículo científico publicado en 2017

Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.

artículo científico publicado en 2018

Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway

artículo científico publicado en 2013

Glioma tropism of lentivirally transduced hematopoietic progenitor cells.

artículo científico publicado en 2010

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells

artículo científico publicado en 2012

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial

artículo científico publicado en 2019

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma

artículo científico publicado en 2018

High frequency of H3 K27M mutations in adult midline gliomas

scientific article published on 04 January 2019

Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study

artículo científico publicado en 2017

INHIBITING INVASION AND STEMNESS IN GLIOBLASTOMA BY THYMOSIN BETA 4 GENE SILENCING: A POTENTIAL THERAPEUTIC TARGET?

artículo científico publicado en 2014

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

artículo científico publicado en 2018

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

artículo científico publicado en 2019

Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis

scientific article published on 04 January 2019

In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.

artículo científico publicado en 2018

In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.

artículo científico publicado en 2017

In vivo molecular profiling of human glioma using diffusion kurtosis imaging

artículo científico publicado en 2016

In vivo visualization of prostate-specific membrane antigen in glioblastoma.

artículo científico publicado en 2014

Integrative assessment of brain and bone invasion in meningioma patients

artículo científico publicado en 2019

Integrin control of the transforming growth factor-β pathway in glioblastoma.

artículo científico publicado en 2013

Intraspinal intradural nodular fasciitis mimicking glioblastoma metastasis: a case report

artículo científico publicado en 2018

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

artículo científico publicado en 2006

Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells

artículo científico publicado en 2005

Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.

artículo científico publicado en 2016

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

scientific article published on 14 February 2019

Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.

artículo científico publicado en 2017

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

artículo científico publicado en 2015

MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T.

artículo científico publicado en 2016

Malignant astrocytoma in elderly patients: where do we stand?

artículo científico publicado en 2013

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma

scholarly article by Srinath Rajaraman et al published 29 March 2019 in Molecular therapy oncolytics

Melanoma brain metastases : Treatment options

artículo científico publicado en 2016

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition

artículo científico publicado en 2015

Molecular diagnostics of gliomas: the clinical perspective

artículo científico publicado en 2010

Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.

artículo científico publicado en 2017

Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography

artículo científico publicado en 2012

Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography

artículo científico publicado en 2013

Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas

scientific article published on 01 February 2019

PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo

artículo científico publicado en 2016

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy

scientific article published on 09 December 2019

Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: A retrospective observational single center study.

artículo científico publicado en 2015

Primary amyloidoma of the brain parenchyma

artículo científico publicado en 2005

Primetime for antiangiogenic therapy

artículo científico publicado en 2009

Proceedings of the WFNS Neuro-Oncology Committee Workshop Rome 2015.

artículo científico publicado en 2016

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

artículo científico publicado en 2013

Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.

artículo científico publicado en 2017

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

artículo científico publicado en 2017

Quantitative mRNA expression analysis of neurotrophin-receptor TrkC and oncogene c-MYC from formalin-fixed, paraffin-embedded primitive neuroectodermal tumor samples

artículo científico publicado en 2006

Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis

artículo científico publicado en 2019

Retrospective analysis of fractionated intensity-modulated radiotherapy (IMRT) in the interdisciplinary management of primary optic nerve sheath meningiomas

scientific article published on 27 December 2019

Risk Factors of Preoperative and Early Postoperative Seizures in Patients with Meningioma: A Retrospective Single-Center Cohort Study

artículo científico publicado en 2016

Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?

scientific article published on September 2010

Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma

artículo científico publicado en 2010

Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach?

artículo científico publicado en 2011

Synergistic antiglioma activity of radiotherapy and enzastaurin

artículo científico publicado en 2007

Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases

scientific article published on 03 February 2013

Targeting integrins in malignant glioma

artículo científico publicado en 2010

Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells

artículo científico publicado en 2017

Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.

artículo científico publicado en 2014

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

artículo científico publicado en 2012

The management of lomustine overdose in malignant glioma patients

artículo científico publicado en 2014

The prognostic impact of ventricular opening in glioblastoma surgery: a retrospective single center analysis.

artículo científico

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy

artículo científico publicado en 2020

The role of integrins in glioma biology and anti-glioma therapies

artículo científico publicado en 2011

The role of integrins in primary and secondary brain tumors

artículo científico publicado en 2016

Thymosin β 4 gene silencing decreases stemness and invasiveness in glioblastoma

artículo científico

Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF

artículo científico publicado en 2019

VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells

artículo científico publicado en 2008

Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case report

artículo científico publicado en 2008

Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma

artículo científico publicado en 2019

Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression

artículo científico publicado en 2003

[Challenges and future perspectives in neuro-oncology]

scientific article published on 01 June 2019

[Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].

artículo científico publicado en 2014

[Interdisciplinary neuro-oncology: part 2: systemic therapy of primary brain tumors].

artículo científico publicado en 2014

[Neuro-Oncology]

artículo científico publicado en 2019

Lista de obras de Ghazaleh Tabatabai

A Phase Ib/II, open-label, multicenter study of INC280 (capmatinib) alone and in combination with buparlisib (BKM120) in adult patients with recurrent glioblastoma

ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial

APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo

ATRX immunostaining predicts IDH and H3F3A status in gliomas

Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

Actively personalized vaccination trial for newly diagnosed glioblastoma

Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas

Angiogenesis inhibition in neurooncology. A very promising therapy strategy for malignant glioma

Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial.

CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake

CS-35TGF-β INDUCES AND BMP SUPPRESSES VEGF RELEASE DEPENDING ON SMAD2/3 VERSUS SMAD1/5/8 SIGNALING IN GLIOBLASTOMA.

Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas

Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro

Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression

Clinical implications of molecular neuropathology and biomarkers for malignant glioma

Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival

Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial

Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis

De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival

Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups

Diagnostic value of WT1 in neuroepithelial tumours

Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma

Effect of Perfusion on Diffusion Kurtosis Imaging Estimates for In Vivo Assessment of Integrated 2016 WHO Glioma Grades : A Cross-Sectional Observational Study

Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma

Elevated HLA-E levels in human glioblastomas but not in grade I to III astrocytomas correlate with infiltrating CD8+ cells.

Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.

Erratum to: In vivo molecular profiling of human glioma using diffusion kurtosis imaging

Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence.

Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survival

GDF-15 contributes to proliferation and immune escape of malignant gliomas

Glioblastoma stem cells ⬇️

Glioblastoma: State of the Art and Future Perspectives

Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion

Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium.

Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway

Glioma tropism of lentivirally transduced hematopoietic progenitor cells.

HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells

Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma

High frequency of H3 K27M mutations in adult midline gliomas

Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study

INHIBITING INVASION AND STEMNESS IN GLIOBLASTOMA BY THYMOSIN BETA 4 GENE SILENCING: A POTENTIAL THERAPEUTIC TARGET?

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma

Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis

In Vivo Molecular Profiling of Human Glioma : Cross-Sectional Observational Study Using Dynamic Susceptibility Contrast Magnetic Resonance Perfusion Imaging.

In vivo assessment of tumor heterogeneity in WHO 2016 glioma grades using diffusion kurtosis imaging: Diagnostic performance and improvement of feasibility in routine clinical practice.

In vivo molecular profiling of human glioma using diffusion kurtosis imaging

In vivo visualization of prostate-specific membrane antigen in glioblastoma.

Integrative assessment of brain and bone invasion in meningioma patients

Integrin control of the transforming growth factor-β pathway in glioblastoma.

Intraspinal intradural nodular fasciitis mimicking glioblastoma metastasis: a case report

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells

Limited role for transforming growth factor-β pathway activation-mediated escape from VEGF inhibition in murine glioma models.

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial

Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas.

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial

MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T.

Malignant astrocytoma in elderly patients: where do we stand?

Measles Virus-Based Treatments Trigger a Pro-inflammatory Cascade and a Distinctive Immunopeptidome in Glioblastoma

Melanoma brain metastases : Treatment options

Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition

Molecular diagnostics of gliomas: the clinical perspective

Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.

Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography

Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography

Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas

PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo

Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy

Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors: A retrospective observational single center study.

Primary amyloidoma of the brain parenchyma

Primetime for antiangiogenic therapy

Proceedings of the WFNS Neuro-Oncology Committee Workshop Rome 2015.

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation